DS Nelson Trainee Prize Presentation

References

• Bates GJ, Fox SB, Han C, et al. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorbeta in primary invasive breast carcinomas. Breast Cancer Res Treat 2008; 111: 453–9
   PubMed Web of Science ®Google Scholar
• Roche Diagnostics. Acetaminophen Package Insert, 2006–12.
   Google Scholar
• RCPA Chemical Pathology QAP. End of Cycle Report for Paracetamol. May 2008.
   Google Scholar
• Burtis CA, Ashwood ER, Bruns DE. Tietz Fundamentals of Clinical Chemistry. 6th ed. St Louis: Saunders, 2008; 569–70.
   Google Scholar
• Desachy A, Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometer in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008; 83: 400–5
   PubMed Web of Science ®Google Scholar
• Kroll H, Maher TR. Significant hypoglycemia secondary to icodextrin dialysate in a diabetic patient. Crit Care Trau 2007; 104: 1473–4
   Google Scholar
• Oyibo SO, Pritchard MG, Mclay E, , et al. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med 2002; 19: 693–6.
   PubMed Web of Science ®Google Scholar
• Teruko O, Shojiro K, Kiyoaki W. Interference in turbidimetric immunoassay for serum C-reactive protein due to serum protein abnormalities in immune complex and rheumatoid factor. Rinsho Byori/Jpn J Clin Pathol 2000; 48: 752–9
   Google Scholar
• Daly ML, Cartwright DJ, Lehner PJ, Javid B. A 58 year old woman with abdominal symptoms and elevated C-reactive protein. PLoS Med 2008; 5: 1050–2
   Google Scholar
• Manivel C, Wick MR, Mukai K. Pilomatrix carcinoma: an immunohistochemical comparison with benign pilomatrixoma and other benign cutaneous lesions of pilar origin. J Cutan Pathol 1986; 13: 22–9
   Google Scholar
• Senger RD, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993; 12: 302–24
   Google Scholar
• Findeisen R, Albrecht S, Richter B, et al. Chemiluminometric determination of tissue polypeptide antigen (TPA) cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothel growth factor (VEGF) in follow-up of breast cancer. Luminescence 2000; 15: 283–9
   PubMed Web of Science ®Google Scholar
• Bast RC, Ravdin P, Hayes DF, et al. update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 2000; 19: 1865–78
   Google Scholar
• DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, 2004.
   Google Scholar
• Serhat A, Lawrence ES, Antoni R, Francisco T, Rajalaxmi M, Jules EH. Hurthle cell carcinoma. eMedicine 2008 ( http://emedicine.medscape.com/article/279462-overview, accessed Dec 2008).
   Google Scholar
• Austin RM. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction. Arch Pathol Lab Med 1997; 121: 227–8
   Google Scholar
• Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827–41
   PubMed Web of Science ®Google Scholar
• Hutchinson ML, Berger BM, Farber FL. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity. Am J Manag Care 2000; 6: 766–80
   Google Scholar
• Stein SR. Thinprep versus the conventional Papanicolaou test: A review of specimen adequacy, sensitivity and cost-effectiveness. Primary Care Update Ob/Gyns 2003; 10: 310–3
   Google Scholar
• Barter PJ. HDL cholesterol testing: implications for clinical management. Australian Prescriber 1994; 17: 99–102
   Google Scholar
• Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: From ultracentrifugation to homogenous assays. Clin Chem 2001; 47: 1579–96
   PubMed Web of Science ®Google Scholar
• Wigglesworth JS. Performance of the perinatal autopsy. Perinatal Pathology, JS Wigglesworth. WB Saunders, Philadelphia 1984
   Google Scholar
• Pryse-Davies J. The perinatal autopsy. In: Anthony PP, MacSween RWM. Recent Advances in Histopathology. Vol II. Edinburgh: Churchill-Livingstone, 1981; 65–82.
   Google Scholar
• Keeling JW, Khong TY. Fetal and Neonatal Pathology4th ed. Springer, London 2007
   Google Scholar
• Merlini E, Lelli Chiesa P. Obstructive ureterocele – an ongoing challenge. World J Urol 2004; 22: 107–14
   PubMed Web of Science ®Google Scholar
• Alvarado-Garcia R, Gallego-Grijalva J, Garcia-Arano G. Ureterocele in children. (Spanish). Cir Cir 2004; 72: 117–20
   Google Scholar
• Brueziere J. Ureteroceles. Ann Urol (Paris) 1992; 26: 202–11
   Google Scholar
• Bederti O, Scalercio F, Aprigliano D, Tsalikova E, Matrunola M, Principessa L. Bilateral intravesical ureteroceles associated with hydroureteronephrosis and hyperechogenic spots in kidneys. Report of a neonatal case. Minerva Pediatr 2000; 52: 69–73
   Google Scholar
• AIHW and AACR. Cancer in Australia 2001. Canberra: AIHW and AACR, 2001.
   Google Scholar
• AIHW and AACR. Cancer in Australia: An Overview 2006. Canberra: AIHW and AACR, 2007.
   Google Scholar
• Williamson JB, Graham S, Clark RB. “Hot Issues” Study No. 2. Melanoma Medical Defence Outlook 2007; 14: 6–11
   Google Scholar
• Gallardo EP, Rojas-Garcia RM, de Luna NP, et al. Inflammation in dysferlin myopathy: immunohistochemical characterisation of 13 patients. Neurology 2001; 57: 2136–8
   PubMed Web of Science ®Google Scholar
• Amato A, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology 2003; 61: 288–9
   PubMed Web of Science ®Google Scholar
• Confalonieri P, Oliva L, Andretta F, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol 2003; 142: 130–6
   Google Scholar
• Fahal AH. Mycetoma: Clinicopathologic Monograph. Khartoum University Press, Khartoum 2006; 7–18
   Google Scholar
• El Hag IA, Fahal AH, Gasim ET. Fine needle aspiration cytology of mycetoma. Acta Cytol 1996; 40: 461–4
   PubMed Web of Science ®Google Scholar
• Gabhane SK, Gangane N, Anshu. Cytodiagnosis of eumycotic mycetoma: a case report. Acta Cytol 2008; 52: 354–6
   Google Scholar
• Fernando SS, Jones P, Vaz R. Fine needle aspiration of a pulmonary mycetoma. A case report and review of the literature. Pathology 2005; 37: 322–4
   PubMed Web of Science ®Google Scholar
• Ho KJ. Papillary parathyroid adenoma. A rare occurrence and its importance in differentiation from papillary carcinoma of the thyroid. Arch Pathol Lab Med 1996; 120: 883–4
   Google Scholar
• Sahin A, Robinson RA. Papillae formation in parathyroid adenoma. A source of possible diagnostic error. Arch Pathol Lab Med 1988; 112: 99–100
   Google Scholar
• Huang A, Fone PD, Gandour-Edwards R, Devere White RW, Low RK. Immunohistochemical analysis of Bcl-2 protein expression in renal cell carcinoma. J Urol 1999; 162: 610–3
   PubMed Web of Science ®Google Scholar
• Gupta PK, Majumder SK, Uppal A. Breast cancer diagnosis using N2 laser excited autofluorescence spectroscopy. Lasers Surg Med 1997; 21: 417–22
   PubMed Web of Science ®Google Scholar
• Jakubowski DB, Cerussi AE, Bevilacqua F, et al. Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt 2004; 9: 230–8
   PubMedGoogle Scholar